Baijin Life Science Holdings Limited (1466.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 497.63M |
| Enterprise Value | 482.93M |
| P/E Ratio | -16.04 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 9.4 |
| Price/Book Ratio | 4.37 |
| Enterprise/Revenue | 9.23 |
| Enterprise/EBITDA | -22.44 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.42 |
| Operating Margin | -0.38 |
AD
Management Effectiveness
| Return On Assets | -0.14 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 89.3M |
| Revenue/Share | 0.1 |
| Gross Profit | 6.67M |
| EBITDA | -38.37M |
| Net Income | -37.87M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 43.11M |
| Total Cash/Share | 0.05 |
| Total Debt | 28.41M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 2.97 |
| Book Value Per Share | 0.21 |
Price History
| 52-Week Change | 38.46 |
| 52-Week High | 1.7 |
| 52-Week Low | 0.47 |
| Moving Average 50 Days | 0.98 |
| Moving Average 200 Days | 0.66 |
Statistics
| Average Volume | 1.75M |
| Shares Outstanding | 932.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 61:58 |
| Last Split Date | April 06, 2022 |
AD
